T/CAPC 015-2024 Active Group standards

T/CAPC 015-2024 Pharmaceutical Service Standards for Retail Pharmacies Operating Thyroid Disease Treatment Drugs

T/CAPC 015-2024

Publish Date: 2024-07-29 Implement Date: 2024-07-29 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Download

Basic Information

Standard Code: T/CAPC 015-2024

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: -

ICS Name: Integrated services

Publish Date: 2024-07-29

Implement Date: 2024-07-29

Pages: 24 pages

Scope

Scope: This document applies to retail pharmacies providing pharmaceutical services to patients with thyroid diseases receiving home treatment, offering screening recommendations for high-risk groups of thyroid diseases, and serving as a reference for public education on thyroid health. The thyroid diseases mentioned in this document refer solely to hypothyroidism, hyperthyroidism, and thyroid nodules. Main technical content: Retail pharmacies should provide comprehensive health management and pharmaceutical services to the public and patients with thyroid diseases, covering all stages from entering the pharmacy to home treatment, including patient consultation, medication evaluation, prescription review, dispensation and delivery, medication guidance, health education, establishing a medication history, and follow-up. While providing thyroid treatment drugs and related products, retail pharmacies should raise public awareness of thyroid diseases and prevention, help high-risk groups identify thyroid diseases early, guide patients with thyroid diseases to clarify treatment goals, understand treatment plans, improve treatment compliance, and enhance disease management quality.